Interventional Pain Treatments for Cancer Pain
Authors:
- 29 September 2008
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1138 (1) , 299-328
Abstract
Cancer pain is prevalent and often multifactorial. For a segment of the cancer pain population, pain control remains inadequate despite full compliance with the WHO analgesic guidelines including use of co‐analgesics. The failure to obtain acceptable pain or symptom relief prompted the inclusion of a fourth step to the WHO analgesic ladder, which includes advanced interventional approaches. Interventional pain‐relieving therapies can be indispensable allies in the quest for pain reduction among cancer patients suffering from refractory pain. There are a variety of techniques used by interventional pain physicians, which may be grossly divided into modalities affecting the spinal canal (e.g., intrathecal or epidural space), called neuraxial techniques and those that target individual nerves or nerve bundles, termed neurolytic techniques. An array of intrathecal medications are infused into the cerebrospinal fluid in an attempt to relieve refractory cancer pain, reduce disabling adverse effects of systemic analgesics, and promote a higher quality of life. These intrathecal medications include opioids, local anesthetics, clonidine, and ziconotide. Intrathecal and epidural infusions can serve as useful methods of delivering analgesics quickly and safely. Spinal delivery of drugs for the treatment of chronic pain by means of an implantable drug delivery system (IDDS) began in the 1980s. Both intrathecal and epidural neurolysis can be effective in managing intractable cancer‐related pain. There are several sites for neurolytic blockade of the sympathetic nervous system for the treatment of cancer pain. The more common sites include the celiac plexus, superior hypogastric plexus, and ganglion impar. Today, interventional pain‐relieving approaches should be considered a critical component of a multifaceted therapeutic program of cancer pain relief.Keywords
This publication has 112 references indexed in Scilit:
- Combined neurolytic block of celiac, inferior mesenteric, and superior hypogastric plexuses for incapacitating abdominal and/or pelvic cancer painJournal of Anesthesia, 2005
- Management of Intrathecal Catheter-Tip Inflammatory Masses: A Consensus StatementPain Medicine, 2002
- Prevalence of symptoms among patients with advanced cancer: An international collaborative studyJournal of Pain and Symptom Management, 1996
- Intraspinal opioid therapy for chronic nonmalignant pain: Current practice and clinical guidelinesJournal of Pain and Symptom Management, 1996
- Unilateral celiac plexus blockJournal of Pain and Symptom Management, 1996
- Long-term intraspinal infusions of opioids in the treatment of neuropathic painJournal of Pain and Symptom Management, 1995
- Opioid rotation for toxicity reduction in terminal cancer patientsJournal of Pain and Symptom Management, 1995
- Spinal analgesia in terminal care: Risk versus benefitJournal of Pain and Symptom Management, 1994
- Epidural opiates and local anesthetics for the management of cancer painPain, 1991
- Epidural versus intrathecal morphine-bupivacaine: Assessment of consecutive treatments in advanced cancer painJournal of Pain and Symptom Management, 1990